---  
layout: startup_page  
title: "Alterome Therapeutics"  
id: "alterome.com"  
permalink: "/alterometherapeuticsalterome.com04032024/"  
website: "https://www.alterome.com"  
funding_round: "Series B"  
funding_amount: "$132M"  
investors: "Goldman Sachs Alternatives, Canaan Partners, Driehaus Capital Management, Invus, Digitalis Ventures, Blue Owl Capital, Orbimed, Nextech Invest, Vida Ventures, Boxer Capital, Colt Ventures"  
about: "Alterome Therapeutics is a biopharmaceutical company developing next-generation, small molecule targeted therapies for cancer treatment. They utilize a structure-guided machine learning approach (Kraken platform) to create precision therapies targeting specific cancer-causing mutations, enhancing safety and efficacy. Their pipeline includes inhibitors targeting AKT1 E17K and KRAS mutations."  
markets: "Biotechnology, Oncology, Precision Medicine"  
hq: "San Diego, California, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/alterome/"  
twitter: "https://twitter.com/AlteromeTx"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/alterome-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/490275-73"  

date_display: "03-Apr-2024"  
date: "2024-04-03"

# SEO Optimization  
meta_title: "Alterome Therapeutics - Series B Funding ($132M)"  
meta_description: "Alterome Therapeutics, Alterome Therapeutics is a biopharmaceutical company developing next-generation, small molecule targeted therapies for cancer treatment. They utilize ..."  
meta_keywords: "Alterome Therapeutics, Biotechnology, Oncology, Precision Medicine, Series B funding"  
canonical_url: "https://startup.projectstartups.com/alterometherapeuticsalterome.com04032024/"  
---